Implore Pharma Private Limited
About Implore Pharma Private Limited
Data last updated:
Implore Pharma Private Limited is a private limited company based in Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 02 December 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2010PTC211032. Its GSTIN is 07AACCI4734Q1Z4 (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vipin Anand and Vivekanand Aggarwal.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Kh. No. 391 Shop No.2 Saroop Nagar (Near J P School), Delhi, India – 110042.
As per the financials filed for FY 2019, the company reported a revenue of ₹12.02 Lakh, a growth of 2% compared to the previous year. For the same year it recorded a net loss of ₹3,555 (net margin -0.3%) and EBITDA of -₹1,449 (EBITDA margin -0.1%). Revenue has declined at a compounded annual rate (CAGR) of 27% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressKh. No. 391 Shop No.2 Saroop Nagar (Near J P School), Delhi, India – 110042
- IndustryTrading, Other Wholesale, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Implore Pharma Private Limited
The main business activity of Implore Pharma is support service to organizations. In detail, this covers other support services to organizations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Implore Pharma Private Limited FY 2019 filings available
Implore Pharma Private Limited reported revenue of ₹12.02 Lakh (up 2% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR) of Implore Pharma Private Limited
Revenue rose 2% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 27%. EBITDA fell 117% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Implore Pharma Private Limited
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹1,449 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹3,555 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Implore Pharma Private Limited
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -0.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Implore Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Implore Pharma Private Limited
Implore Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Other support services to organizations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Suhrut Multi Business Solutions Private Limited | ₹12.05 Lakh (FY 2022) | •••• | •••• | 66.0% | •••• | Nizampet Post, Telangana, India |
| Makers Space Business Solutions Private Limited | ₹12.04 Lakh (FY 2025) | •••• | •••• | -18.0% | •••• | Jaipur, Rajasthan, India |
| Rangoli Exports Pvt Ltd | ₹12.04 Lakh (FY 2025) | •••• | •••• | -29.0% | •••• | Kolkata, West Bengal, India |
| Sarvato Multi Solution Private Limited | ₹12.03 Lakh (FY 2025) | •••• | •••• | -39.0% | •••• | New Delhi, Delhi, India |
| Aadharstambh Consultancy Services Private Limited | ₹12.03 Lakh (FY 2025) | •••• | •••• | -68.0% | •••• | Indore, Madhya Pradesh, India |
| Implore Pharma Private Limited this company | ₹12.02 Lakh (FY 2019) | •••• | •••• | 2.0% | •••• | Delhi, India |
| Jeet Superstructure Private Limited | ₹12.02 Lakh (FY 2019) | •••• | •••• | -84.0% | •••• | Mira Road, Maharashtra, India |
| Expert Assistance Services Private Limited | ₹12.02 Lakh (FY 2025) | •••• | •••• | 100.0% | •••• | Coimbatore, Tamil Nadu, India |
| Main Stream Shipping and Trading Pvt Ltd | ₹12.02 Lakh (FY 2025) | •••• | •••• | -75.0% | •••• | Kolkata, West Bengal, India |
| Respublica Consulting Private Limited | ₹12.01 Lakh (FY 2024) | •••• | •••• | -58.0% | •••• | Kakkanadu, Kerala, India |
| Emcee Apparel Sourcing Private Limited | ₹12.01 Lakh (FY 2024) | •••• | •••• | 0.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Implore Pharma by revenue in the same principal business activity (Other support services to organizations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Implore Pharma Private Limited
Implore Pharma Private Limited is audited by U. SHANKER & ASSOCIATES for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| U. SHANKER & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Implore Pharma Private Limited
Implore Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vipin Anand | Director | 02 Dec 2010 | 15 Years 10 Months | Current |
| Vivekanand Aggarwal | Director | 02 Dec 2010 | 15 Years 10 Months | Current |
Ownership and Shareholding of Implore Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Implore Pharma Private Limited
Implore Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Implore Pharma Private Limited
Employment history and EPFO contributions of people linked to Implore Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Implore Pharma Private Limited
Implore Pharma Private Limited has 2 board changes on record since 2010: 2 appointments. The latest: Vipin Anand was appointed as Director on 02 Dec 2010.
Credit Ratings, Litigation & Regulatory Alerts for Implore Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Implore Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Implore Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Implore Pharma Private Limited
Implore Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCI4734Q1Z4 | Delhi | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Implore Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Implore Pharma Private Limited
Implore Pharma is an active private limited company based in Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 02 December 2010 (16+ years old) and is registered under CIN U51909DL2010PTC211032.
Implore Pharma reported revenue of ₹12.02 Lakh for FY 2019 (up 2% YoY).
Implore Pharma has 2 current directors:
- Vipin Anand - Director
- Vivekanand Aggarwal - Director
Implore Pharma reported a net loss of ₹3,555 (net margin -0.3%) and EBITDA of -₹1,449 (EBITDA margin -0.1%) for FY 2019, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Implore Pharma is -27% over three years. In the latest year (FY 2019) revenue rose 2%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Implore Pharma is 07AACCI4734Q1Z4, registered in Delhi.
The CIN (Corporate Identification Number) of Implore Pharma is U51909DL2010PTC211032. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Implore Pharma was incorporated on 02 December 2010, making it 16+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Implore Pharma by revenue are Suhrut Multi Business Solutions Private Limited, Makers Space Business Solutions Private Limited, Rangoli Exports Pvt Ltd, Sarvato Multi Solution Private Limited, Aadharstambh Consultancy Services Private Limited and 5 more, all in the same principal business activity (Other support services to organizations).
Vipin Anand was appointed as Director on 02 Dec 2010. Vivekanand Aggarwal was appointed as Director on 02 Dec 2010.
The registered office of Implore Pharma is at Kh. No. 391 Shop No.2 Saroop Nagar Near J P School, Delhi, India – 110042.